Carry Life@ UF System Clinical Study - Trial NCT05874804
Access comprehensive clinical trial information for NCT05874804 through Pure Global AI's free database. This phase not specified trial is sponsored by Triomed AB and is currently Not yet recruiting. The study focuses on End Stage Renal Disease. Target enrollment is 25 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Triomed AB
Timeline & Enrollment
N/A
Aug 01, 2023
Aug 01, 2024
Primary Outcome
Ultrafiltration volume
Summary
The Carry Life UF system performs peritoneal ultrafiltration by adding glucose to the low
 glucose strength (1.36%) peritoneal dialysis fluid which has been instilled into the
 peritoneal cavity prior to the connection of the device. By maintaining a stable glucose
 concentration in the intraperitoneal fluid during the 5-hour treatment, the ultrafiltration
 can be increased compared to a standard CAPD dwell.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05874804
Device Trial